BioStratum Inc., of Research Triangle Park, N.C., appointed Bengt Samuelsson and Helgi Kristbjarnarson to its board.
Biotica Technology Ltd., of Cambridge, England, appointed Eric Cundliffe, Iain Hunter, Craig Townsend and John Vederas to its scientific advisory board.
Chromos Molecular Systems Inc., of Burnaby, British Columbia, appointed Joseph Zendegui vice president, business development.
Cytran Inc., of Kirkland, Wash., appointed Robert Sims as medical director.
Delsys Pharmaceutical Corp., of Monmouth Junction, N.J., appointed David Friend senior director of formulations.
DiscoveRx Corp., of Fremont, Calif., appointed Jim Richey executive vice president, marketing and sales.
Galen Holdings plc, of Craigavon, Northern Ireland, appointed Thomas Lynch as a non-executive director.
Genetronics Biomedical Ltd., of San Diego, named Mervyn McCulloch chief financial officer.
Interleukin Genetics Inc., of Waltham, Mass., named Paul Martha chief medical officer.
Luminex Corp., of Austin, Texas, appointed Gail Page executive vice president and chief operating officer.
Millennium Pharmaceuticals Inc., of Cambridge, Mass., named Edward Miller to its board of directors.
Ortec International Inc., of New York, added Marc Jacobs as its vice president of product development.
Phylos Inc., of Lexington, Mass., appointed Albert Collinson vice president of business development.
The Biotechnology Industry Organization, of Washington, named Matthew Lyons director of government relations for food and agriculture.
V.I. Technologies Inc., of Watertown, Mass., promoted Bernadette Alford to executive vice president, having responsibility for research and development, clinical and regulatory affairs, and John Chapman was named senior vice president of blood products research.
Variagenics Inc., of Cambridge, Mass., appointed Ellen Zane to its board.